MINERVA NEUROSCIENCES, INC. - Common Stock, par value $0.0001 per share (NERV) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2014 to Q4 2025

Type / Class: Equity / Common Stock, par value $0.0001 per share
Symbol: NERV on Nasdaq
Shares outstanding: 44,124,265
Price per share: $4.02
All holders as of 31 Dec 2025: Q4 2025
Total 13F shares: 415
Total reported value: $1,668
% of total 13F portfolios: 0%
Share change: +303
Value change: +$1,218
Number of holders: 3

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of MINERVA NEUROSCIENCES, INC. - Common Stock, par value $0.0001 per share (NERV) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
Boehringer AG	3.4%				1,500,225		Boehringer AG	23 Dec 2025

As of 31 Dec 2025, 3 institutional investors reported holding 415 shares of MINERVA NEUROSCIENCES, INC. - Common Stock, par value $0.0001 per share (NERV). This represents 0% of the company’s total 44,124,265 outstanding shares.

Institutional Holders of MINERVA NEUROSCIENCES, INC. - Common Stock, par value $0.0001 per share (NERV) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2025 Q4	415	$1,668	+$1,218			$4.02	3
2025 Q3	112	$236				$2.10	2
2025 Q2	112	$193				$1.74	2
2025 Q1	112	$175	+$155			$1.61	2
2024 Q4	12	$27				$2.25	1
2024 Q3	12	$32				$2.67	1
2024 Q2	12	$38				$3.17	1
2024 Q1	12	$31				$2.58	1
2023 Q4	12	$74				$6.17	1
2023 Q3	12	$83				$6.92	1
2023 Q2	12	$110				$9.17	1
2023 Q1	12	$19				$1.58	1
2022 Q4	12	$19				$1.58	1
2022 Q3	12	$111				$9.25	1
2022 Q2	12	$40	-$16,337,293	$0	$0	$3.33	1
2022 Q1	19,689,879	$16,337,525	-$863,545	$20,000	$180,000	$0.83	29
2021 Q4	20,744,729	$16,612,507	-$5,906,710	$71,000	$197,000	$0.80	32
2021 Q3	24,679,145	$42,932,181	-$5,257,934	$378,000	$740,000	$1.74	45
2021 Q2	27,228,671	$63,166,575	-$9,652,548	$274,000	$739,000	$2.32	67
2021 Q1	31,289,978	$91,361,861	+$6,057,110	$297,000	$531,000	$2.92	70
2020 Q4	29,276,106	$68,503,351	-$2,555,981	$287,000	$28,000	$2.34	73
2020 Q3	29,549,949	$93,977,229	+$6,283,342	$298,000	$216,000	$3.18	70
2020 Q2	27,516,934	$99,332,361	-$26,781,537	$4,314,000	$2,952,000	$3.61	73
2020 Q1	31,966,513	$192,441,137	-$3,153,115	$2,497,000	$10,755,000	$6.02	89
2019 Q4	32,380,977	$230,222,642	-$567,943	$117,000	$674,000	$7.11	92
2019 Q3	30,787,881	$238,626,130	+$14,851,470	$148,000	$111,000	$7.75	86
2019 Q2	28,240,660	$158,927,724	-$5,140,594	$110,000	$66,000	$5.63	84
2019 Q1	29,156,983	$229,166,934	+$2,934,142		$0	$7.86	78
2018 Q4	29,723,829	$200,330,177	+$3,083,488		$249,000	$6.74	83
2018 Q3	29,208,287	$366,569,784	+$5,119,795		$318,000	$12.55	82
2018 Q2	28,833,995	$237,880,599	+$5,644,257		$118,000	$8.25	71
2018 Q1	28,244,089	$176,525,294	+$973,212			$6.25	66
2017 Q4	28,116,792	$170,104,473	-$9,496,766	$0		$6.05	66
2017 Q3	28,510,831	$216,759,518	-$8,801,064	$112,000	$0	$7.60	69
2017 Q2	29,447,458	$260,701,488	+$37,169,131	$183,000	$941,000	$8.85	82
2017 Q1	25,344,569	$205,254,664	+$9,372,863		$83,000	$8.10	71
2016 Q4	24,715,841	$290,417,502	+$6,431,071			$11.75	77
2016 Q3	24,141,417	$340,747,764	+$31,786,257			$14.11	67
2016 Q2	22,034,711	$224,973,456	+$99,296,302			$10.21	64
2016 Q1	12,353,055	$75,841,000	+$20,076,269			$6.14	28
2015 Q4	9,082,712	$55,131,000	+$940,040			$6.07	21
2015 Q3	8,893,423	$46,688,000	+$485,651			$5.25	17
2015 Q2	8,794,630	$51,005,000	+$6,477,355		$0	$5.80	18
2015 Q1	7,722,580	$34,734,000	+$24,031,296		$607,903,000	$5.00	15
2014 Q4	2,086,400	$12,589,000	-$942,897			$6.03	9
2014 Q3	2,242,910	$13,566,000	+$13,566,000			$6.05	11